Compare Humana Inc (HUM) vs Wynn Resorts, Limited (WYNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Wynn Resorts, Limited — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Wynn Resorts, Limited trades at $104.65 (market cap $10.55B). The key difference: Humana Inc is far larger — about 4.4× Wynn Resorts, Limited's market cap, and Wynn Resorts, Limited pays the higher dividend (0.98%). Which is the better fit depends on your goals.
| HUM | WYNN | |
|---|---|---|
Market Cap | $46.31B | $10.55B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $133.34 |
52-Week Low | $163.67 | $94.37 |
Enterprise Value | $53.67B | $20.80B |
Dividend Yield | 0.92% | 0.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Wynn Resorts (WYNN) trades at $102.54, up 1.02% today, with a bullish technical signal from moving averages and support at $101. The company reported Q2 2026 earnings of $1.24 per share, beating estimates, driven by strong performance in Macau. Revenue trends show growth from $3.8B in 2022 to $7.4B projected for 2026, though net margins have fluctuated. Recent news highlights institutional buying and CapEx plans for new resorts.
The outlook is positive with a consensus price target of $133, implying 30% upside, supported by analyst bullishness (64% buy ratings). Risks include high debt levels ($10.5B long-term) and sensitivity to tourism cycles. Earnings consistency and Macau's recovery remain key catalysts for investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Wynn Resorts, Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →
